Patents by Inventor Randall John Bateman

Randall John Bateman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS FOR MEASURING THE METABOLISM OF NEURALLY DERIVED BIOMOLECULES IN VIVO
    Publication number: 20160139142
    Abstract: The present invention relates to methods of diagnosing, monitoring, and assessing treatment effects for neurological and neurodegenerative diseases and disorders, such as Alzheimer's Disease, early in the course of clinical disease or prior to the onset of brain damage and clinical symptoms. Methods of measuring the in vivo metabolism of biomolecules produced in the CNS in a subject are provided.
    Type: Application
    Filed: November 18, 2015
    Publication date: May 19, 2016
    Inventors: Randall John Bateman, David Michael Holtzman
  • METHODS FOR MEASURING THE METABOLISM OF NEURALLY DERIVED BIOMOLECULES IN VIVO
    Publication number: 20140199718
    Abstract: The present invention relates to methods of diagnosing, monitoring, and assessing treatment effects for neurological and neurodegenerative diseases and disorders, such as Alzheimer's Disease, early in the course of clinical disease or prior to the onset of brain damage and clinical symptoms. Methods of measuring the in vivo metabolism of biomolecules produced in the CNS in a subject are provided.
    Type: Application
    Filed: March 25, 2014
    Publication date: July 17, 2014
    Applicant: The Washington University
    Inventors: Randall John Bateman, David Michael Holtzman
  • METHODS FOR MEASURING THE METABOLISM OF NEURALLY DERIVED BIOMOLECULES IN VIVO
    Publication number: 20120282642
    Abstract: The present invention relates to methods of diagnosing, monitoring, and assessing treatment effects for neurological and neurodegenerative diseases and disorders, such as Alzheimer's Disease, early in the course of clinical disease or prior to the onset of brain damage and clinical symptoms. Methods of measuring the in vivo metabolism of biomolecules produced in the CNS in a subject are provided.
    Type: Application
    Filed: June 27, 2012
    Publication date: November 8, 2012
    Applicant: THE WASHINGTON UNIVERSITY
    Inventors: Randall John Bateman, David Michael Holtzman
  • Methods for measuring the metabolism of neurally derived biomolecules in vivo
    Patent number: 8232107
    Abstract: The present invention relates to methods of diagnosing, monitoring, and assessing treatment effects for neurological and neurodegenerative diseases and disorders, such as Alzheimer's Disease, early in the course of clinical disease or prior to the onset of brain damage and clinical symptoms. Methods of measuring the in vivo metabolism of biomolecules produced in the CNS in a subject are provided.
    Type: Grant
    Filed: January 12, 2011
    Date of Patent: July 31, 2012
    Assignee: Washington University in St. Louis
    Inventors: Randall John Bateman, David Michael Holtzman
  • METHODS FOR MEASURING THE METABOLISM OF NEURALLY DERIVED BIOMOLECULES IN VIVO
    Publication number: 20110111511
    Abstract: The present invention relates to methods of diagnosing, monitoring, and assessing treatment effects for neurological and neurodegenerative diseases and disorders, such as Alzheimer's Disease, early in the course of clinical disease or prior to the onset of brain damage and clinical symptoms. Methods of measuring the in vivo metabolism of biomolecules produced in the CNS in a subject are provided.
    Type: Application
    Filed: January 12, 2011
    Publication date: May 12, 2011
    Applicant: THE WASHINGTON UNIVERSITY
    Inventors: Randall John Bateman, David Michael Holtzman
  • Methods for measuring the metabolism of neurally dervied biomolecules in vivo
    Patent number: 7892845
    Abstract: The present invention relates to methods of diagnosing, monitoring, and assessing treatment effects for neurological and neurodegenerative diseases and disorders, such as Alzheimer's Disease, early in the course of clinical disease or prior to the onset of brain damage and clinical symptoms. Methods of measuring the in vivo metabolism of biomolecules produced in the CNS in a subject are provided.
    Type: Grant
    Filed: April 4, 2006
    Date of Patent: February 22, 2011
    Assignee: Washington University in St. Louis
    Inventors: Randall John Bateman, David Michael Holtzman
  • Methods for Measuring the Metabolism of Neurally Dervied Biomolecules in Vivo
    Publication number: 20080145941
    Abstract: The present invention relates to methods of diagnosing, monitoring, and assessing treatment effects for neurological and neurodegenerative diseases and disorders, such as Alzheimer's Disease, early in the course of clinical disease or prior to the onset of brain damage and clinical symptoms. Methods of measuring the in vivo metabolism of biomolecules produced in the CNS in a subject are provided.
    Type: Application
    Filed: April 4, 2006
    Publication date: June 19, 2008
    Applicant: WASHINGTON UNIVERSITY IN ST. LOUIS
    Inventors: Randall John Bateman, David Michael Holtzman